# HOIST Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hoist-co

- Industry: Pharmaceuticals
- Headquarters: Japan
- Website: www.hoist-jp.com
- Total disclosed funding: $9.1M
- Latest round: Series A (May 9, 2023)
- Investors on record: 1

## About

Based in Osaka, Japan, and founded in 2019, HOIST Co., Ltd. operates as a pharmaceutical research and development company specializing in cancer treatment drugs. In April 2023, the firm raised JPY 300 million in venture funding led by investor Osaka University Venture Capital. The firm as of April 2023, is led by its President and Representative Director, Chihaya Kakinuma.

The company engages in the research, development, consultancy, and sale of prescription drugs and drug discovery equipment for cancer treatment. The other services offered by the firm are consulting on industry-academia collaboration, research and development, manufacturing, sales, and consulting of health tech products. HOIST also offers a variety of healthcare information services over the Internet. As of April 2023, the products in the company’s pipeline are bladder cancer drugs and epi transcriptomics drug discovery.

The company plans to utilize its April 2023 funding to support and accelerate the development of its therapeutic drug for Bladder cancer.

## Funding rounds

- Series A, May 9, 2023, $5.9M — Osaka University Venture Capital
- Series A, Jan 1, 2022, $0.9M — Osaka University Venture Capital
- Series A, Nov 27, 2020, $1.4M — Osaka University Venture Capital
- Series A, Nov 1, 2019, $0.9M — Osaka University Venture Capital

## Investors

- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A